1. Home
  2. > Healthcare
  3. > Pathology Market Trends
North America Benign Prostatic Hyperplasic Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Procedure Type, and End User

North America Benign Prostatic Hyperplasic Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Procedure Type, and End User

  • October 2022
  • 146 pages
  • ID: 6362113
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The benign prostatic hyperplasic devices market in North America is expected to grow from US$ 863.12 million in 2022 to US$ 1,349.19 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2022 to 2028.
Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate.This noncancerous prostate condition is usually not fatal.

Being benign, the condition does not involve metastasis to other body parts.BPH is not associated with the risk of prostate cancer; moreover, unless it manifests symptoms, BPH isn’t considered a health issue.

Almost all men are likely to have some prostate growth by the time they turn 70.Aging, abdominal obesity, and insufficient physical exercise raise the risk of developing BPH.

According to the National Center for Biotechnology Information (NCBI), BPH is one of the most common disorders in older men and the leading cause of lower urinary tract symptoms (LUTS). After the age of 40, the prevalence of BPH rises, reaching a peak of 60% by the age of 90. Many autopsy studies suggest that the histological prevalence of BPH is 8%, 50%, and 80% in the fourth, sixth, and ninth decades of the life of a man, respectively. Old age has also been shown to be a risk factor for the onset and progression of clinical BPH in observational studies conducted in the US. According to statistics from the Krimpen and Baltimore Longitudinal Study of Aging, the prostate grows at a rate of 2.0–2.5% per year in elderly men. Continued prostate enlargement may develop into LUTS, and larger prostates are associated with a benign prostatic enlargement (BPE), which triggers the risk of developing clinical BPH and urine incontinence. According to the NCBI data, increased adiposity is found to have a positive correlation with prostate volume. In numerous study groups, body weight, body mass index (BMI), and waist circumference have been seen to have a positive correlation with prostate volume. Additionally, epidemiological data shows obesity may raise the need for BPH surgery and BPH treatment.
According to the American Journal of Men’s Health (AJMH), in 2019, globally, there were 11.26 million new cases and 1.86 million YLD due to BPH in 2019. The incidence of BPH increased by 105.7%, and YLD increased by 110.6% worldwide during 1990–2019. The absolute incidence and YLD numbers increased considerably worldwide during this period, primarily, due to population increase and aging. The treatment option for BPH includes surgeries such as transurethral resection of the prostate (TURP), open prostatectomy, and minimally invasive treatments such as transurethral needle ablation (TUNA). Benign prostatic hyperplasic devices are used in minimally invasive treatments such as radiofrequency ablation, laser therapy, and implants. Thus, the increase in the prevalence of benign prostatic hyperplasia and related risk factors bolsters the demand for benign prostatic hyperplasic devices.
North America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)

North America Benign Prostatic Hyperplasic Devices Market Segmentation
The North America benign prostatic hyperplasic devices market is segmented on the basis of product, procedure type, end user, and country.Based on product, the market is segmented into resectoscopes, urology lasers, radiofrequency ablation devices, prostatic stents, and implants.

The resectoscopes segment is expected to hold the largest share of the market in 2022.On the other hand, the urology lasers segment is expected to register the highest CAGR during the forecast period.

Based on procedure type, the North America benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others.The transurethral resection of the prostate segment held the largest market share in 2022, and it is also expected to register the highest CAGR in the market during the forecast period.

Based on end user, the North America benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2022, while the clinics segment is expected to register the highest CAGR during the forecast period. Based on country, the North America benign prostatic hyperplasic devices market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share, and it is further expected to register the highest CAGR during the forecast period.
KARL STORZ SE & Co. KG; Olympus Corporation; Boston Scientific Corporation; Teleflex Incorporated; Richard Wolf GmbH; Urologix, LLC; OmniGuide Holdings, Inc.; and Convergent Laser Technologies are among the leading companies in the North America benign prostatic hyperplasic devices market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Renal Denervation Devices Market Research Report by Technology, Products, Disease Application, End-User, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030

  • $ 3949
  • January 2023
  • 136 pages

Renal Denervation Devices Market Research Report by Technology (Micro-Infusion-Based, Pharmacologic Ablation, and Radiofrequency-Based), Products, Disease Application, End-User, Country - Cumulative Impact ...

  • North America
  • Marketing Research
  • Diagnostics
  • Industry analysis

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on